Preclinical evaluation of Mab CC188 for ovarian cancer imaging

International Journal of Cancer, 04/20/2012

The authors work suggests that Mab CC188–based imaging and therapeutic reagents are capable of detecting early stage ovarian tumors and effectively treating the tumor.

Print Article Summary Cat 2 CME Report